Juno Therapeutics Inc. has appointed Dr. Sunil Agarwal as president of research and development, and the Seattle biotech plans to open an office in the Bay Area.
The newly created position brings Juno's R&D operation under one executive. In this role, Agarwal will be responsible for building out Juno’s drug development pipeline, integrating translational research into ongoing programs and prioritizing new research and development initiatives.
Sign up for our free email newsletters to keep with…
Juno Therapeutics Inc. has appointed Dr. Sunil Agarwal as president of research and development, and the Seattle biotech plans to open an office in the Bay Area.
The newly created position brings Juno's R&D operation under one executive. In this role, Agarwal will be responsible for building out Juno’s drug development pipeline, integrating translational research into ongoing programs and prioritizing new research and development initiatives.
Sign up for our free email newsletters to keep with…